Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors. - Márquez-Rodas I; Longo F; Rodriguez-Ruiz ME; Calles A; Ponce S; Jove M; Rubio-Viqueira B; Perez-Gracia JL; Gómez-Rueda A; López-Tarruella S; Ponz-Sarvise M; Álvarez R; et al. (Science translational medicine, 2020)